Why the study?
Does N-nitro-L-arginine cause coronary vasoconstriction and inhibit endothelium-dependent vasodilatation in anaesthetized greyhounds?
Population
Anaesthetized greyhounds (n=7)
Comparison
N-nitro-L-arginine 5 mg kg-1 infused into the… vs Baseline responses prior to L-NNA administration
Design
Preclinical
Authors
Loading...
Should not inform clinical coronary management; leaves open translation of endothelium-derived NO regulation to human disease.
Does N-nitro-L-arginine cause coronary vasoconstriction and inhibit endothelium-dependent vasodilatation in anaesthetized greyhounds?
Inhibition of nitric oxide biosynthesis with L-NNA causes coronary vasoconstriction and selectively inhibits endothelium-dependent vasodilatation, demonstrating the importance of endothelium-derived NO in regulating coronary vascular tone.
Woodman et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: